Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PLASMA FRACTIONATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PRODUCTION FACILITIES FOR BLOOD PLASMA:
4.2 SUPPLIERS OF PROCESS LINES FOR PLASMA FRACTIONATION
4.2.1 RAW MATERIAL PROCUREMENT
4.2.2 MANUFACTURING
4.2.3 MARKETING & DISTRIBUTION
4.2.4 END-USERS
5 NORTH AMERICA PLASMA FRACTIONATION MARKET: REGULATORY
5.1 THE U.S.
5.2 INDIA
5.3 EUROPE
5.4 BRAZIL
5.5 SOUTH AFRICA
6 MARKET OVERVIEW
6.1 3.1 DRIVERS
6.1.1 3.1.1 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE
6.1.2 RISE IN RESPIRATORY DISEASES ACROSS THE WORLD
6.1.3 INCREASE IN AGING POPULATION WITH BLOOD-RELATED AILMENTS
6.1.4 INCREASE USAGE OF IMMUNOGLOBULIN
6.2 RESTRAINTS
6.2.1 GROWING USAGE OF RECOMBINANT PROTEIN PRODUCTS
6.2.2 STRINGENT GOVERNMENT REGULATIONS REGARDING PLASMA THERAPY
6.2.3 RISK OF QUALITY AND SAFETY
6.3 OPPORTUNITIES
6.3.1 INCREASE IN PLASMA COLLECTION CENTRES
6.3.2 UNHEALTHY LIFESTYLE POSSESS SERIOUS INFLAMMATION RISK
6.3.3 ADVANCEMENT IN TECHNOLOGIES
6.4 CHALLENGES
6.4.1 SHORTAGE OF PLASMA PROTEINS
6.4.2 HIGH COST OF PLASMA THERAPY
7 IMPACT OF COVID-19 ON THE NORTH AMERICA PLASMA FRACTIONATION MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 IMMUNOGLOBULINS
8.2.1 INTRAVENOUS IMMUNOGLOBULINS
8.2.2 SUBCUTANEOUS IMMUNOGLOBULINS
8.2.3 OTHER IMMUNOGLOBULINS
8.3 COAGULATION FACTOR CONCENTRATES
8.3.1 FACTOR IX
8.3.2 FACTOR VIII
8.3.3 FIBRINOGEN CONCENTRATES
8.3.4 PROTHROMBIN COMPLEX CONCENTRATE
8.3.5 VON WILLEBRAND FACTOR
8.3.6 FACTOR XIII
8.4 ALBUMIN
8.5 PROTEASE INHIBITORS
8.6 OTHER PRODUCTS
9 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 IMMUNOLOGY
9.3 HAEMATOLOGY
9.4 CRITICAL CARE
9.5 NEUROLOGY
9.6 PULMONOLOGY
9.7 HAEMATO-ONCOLOGY
9.8 RHEUMATOLOGY
9.9 OTHER APPLICATION
10 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY
10.1 OVERVIEW
10.2 ION-EXCHANGE CHROMATOGRAPHY
10.3 AFFINITY CHROMATOGRAPHY
10.4 ULTRAFILTRATION
10.5 MICROFILTRATION
10.6 CRYOPRECIPITATION
11 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY MODE
11.1 OVERVIEW
11.2 MODERN PLASMA FRACTIONATION
11.3 TRADITIONAL PLASMA FRACTIONATION
12 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS & CLINICS
12.3 CLINICAL RESEARCH LABORATORIES
12.4 ACADEMIC INSTITUTES
12.5 OTHERS
13 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTION
13.4 OTHERS
14 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY REGION
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
15 NORTH AMERICA PLASMA FRACTIONATION MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 CSL PLASMA
17.1.1 COMPANY SNAPSHOT
17.1.2 COMPANY SHARE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 GRIFOLS, S.A.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 OCTAPHARMA AG
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENTS
17.4 KENDRION S.P.A
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 BAXTER
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 ADMA BIOLOGICS INC.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BHARAT SERUMS AND VACCINES LIMITED (BSV)
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIO PRODUCTS LABORATORY LTD.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 BIOTEST AG
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENTS
17.11 BOCCARD
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 CENTURION İLAÇ SANAYI VE TICARET A.Ş.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 GREEN CROSS CORP.
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENTS
17.15 INTAS PHARMACEUTICAL LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 JAPAN BLOOD PRODUCTS ORGANIZATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 KABAFUSION
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 LFB SA
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 MERCK KGAA
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
17.2 NOVASEP HOLDING SAS
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENTS
17.21 PALL CORPORATION
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SANQUIN
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 SHANGHAI RAAS
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENTS
17.25 SK PLASMA
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA ALBUMIN IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA PROTEASE INHIBITORS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA OTHER PRODUCTS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA PLASMA FRACTIONATION MARKET, APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA IMMUNOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA HAEMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA CRITICAL CARE IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA NEUROLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA PULMONOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA HAEMATO-ONCOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA RHEUMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA OTHER APPLICATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA PLASMA FRACTIONATION MARKET, PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA ION-EXCHANGE CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA AFFINITY CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ULTRAFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA MICROFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA CRYOPRECIPITATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA PLASMA FRACTIONATION MARKET, MODE, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA MODERN PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA TRADITIONAL PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA PLASMA FRACTIONATION MARKET, END USER, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA HOSPITALS & CLINICS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA CLINICAL RESEARCH LABORATORIES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA ACADEMIC INSTITUTES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA PLASMA FRACTIONATION MARKET, DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA DIRECT TENDERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA THIRD PARTY DISTRIBUTION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 45 U.S. PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 46 U.S. IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 47 U.S. COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 U.S. PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 U.S. PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 50 U.S. PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 51 U.S. PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 U.S. PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 53 CANADA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 54 CANADA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 55 CANADA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 CANADA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 CANADA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 CANADA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 59 CANADA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 CANADA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 MEXICO PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 62 MEXICO IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 MEXICO COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 MEXICO PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 MEXICO PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 MEXICO PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 67 MEXICO PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 MEXICO PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA PLASMA FRACTIONATION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PLASMA FRACTIONATION MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PLASMA FRACTIONATION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PLASMA FRACTIONATION MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PLASMA FRACTIONATION MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PLASMA FRACTIONATION MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA PLASMA FRACTIONATION MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA PLASMA FRACTIONATION MARKET : VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA PLASMA FRACTIONATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA PLASMA FRACTIONATION MARKET: SEGMENTATION
FIGURE 11 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA PLASMA FRACTIONATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 IMMUNOGLOBULINS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PLASMA FRACTIONATION MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PLASMA FRACTIONATION MARKET
FIGURE 14 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, 2020
FIGURE 15 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION)
FIGURE 16 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, CAGR (2020-2028)
FIGURE 17 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY APPLICATION, 2020
FIGURE 19 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 20 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY APPLICATION, CAGR (2020-2028)
FIGURE 21 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, 2020
FIGURE 23 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, 2020-2028 (USD MILLION)
FIGURE 24 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, CAGR (2020-2028)
FIGURE 25 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, LIFELINE CURVE
FIGURE 26 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY MODE, 2020
FIGURE 27 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY MODE, 2020-2028 (USD MILLION)
FIGURE 28 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY MODE, CAGR (2020-2028)
FIGURE 29 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY MODE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY END USER, 2020
FIGURE 31 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 32 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY END USER, CAGR (2020-2028)
FIGURE 33 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 35 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 36 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)
FIGURE 37 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA PLASMA FRACTIONATION MARKET: SNAPSHOT (2020)
FIGURE 39 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY COUNTRY (2020)
FIGURE 40 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 NORTH AMERICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE (2021 & 2028)
FIGURE 43 NORTH AMERICA PLASMA FRACTIONATION MARKET: COMPANY SHARE 2020 (%)
